1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legislation

Congressional Races Could Alter Cosmetics Legislative Outlook, Starting With House Energy & Commerce

 
• By Lauren Nardella

Recent polling suggests the “blue wave” headed for Congress may not be of the magnitude hyped by some. But if Dems do flip the House as expected, cosmetics reform legislation will go through an Energy & Commerce Committee likely chaired by New Jersey Rep. Frank Pallone, who’s been a highly vocal critic of current cosmetics safety controls.

Washington DC Capitol dome detail with waving american flag

In Congress's current meeting, Rep. Frank Pallone, D-N.J., has called FDA’s inspection program for imported cosmetics “startling” in its inadequacy, sounded off on asbestos and other contaminated-cosmetic dangers while standing outside a Claire’s store in his district, and repeatedly called for a hearing to promote cosmetics legislative reform efforts.

That hearing, which was promised to be the venue for Pallone’s unveiling of a cosmetics bill he circulated in discussion...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

California Legislators Advance Bill To Ban Plastic Glitter, Abrasive Microbeads In Personal Care

 
• By Lauren Nardella

Lawmakers in California heeded calls from industry to change proposed legislation to avoid a wider ban on microplastics in personal care products.

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 
• By Eileen Francis

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

IBA Interactive Policy Map Is Call To Action As Cosmetics Industry Braces For Myriad Of State Bills

 
• By Eileen Francis

The Independent Beauty Association has launched an interactive Policy Map tracking state and federal bills and filtering by state or topic, pinpointing bills of great priority.

More from Policy & Regulation

California Legislators Advance Bill To Ban Plastic Glitter, Abrasive Microbeads In Personal Care

 
• By Lauren Nardella

Lawmakers in California heeded calls from industry to change proposed legislation to avoid a wider ban on microplastics in personal care products.

EPR Alert! Unregistered Producers In Colorado No Longer Permitted To Sell 1 July

 
• By Eileen Francis

Packaging producers subject to Colorado’s Extended Producer Responsibility program that have not registered with the organization running the program will no longer be able to sell in the state starting 1 July.

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 
• By Eileen Francis

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.